Introduction !
Overweight and obesity are globally the fifth leading risks for death. At least 2.8 million adults die each year as a result of being overweight or obese [1] . Worldwide obesity is so common that it is beginning to replace undernutrition and infectious diseases as the most significant contributor to ill health. Frequently, the risks associated with obesity are diabetes mellitus, coronary heart disease, certain forms of cancer and sleep-breathing disorders [2, 3] . An important target for the treatment of obesity includes the development of inhibitors of nutrient digestion and absorption [4] . Inhibition of pancreatic lipase (PL) and the associated reduction of lipid absorption is an attractive approach for the discovery of potent agents to the treatment of obesity [5] [6] [7] . To find new compounds with PL inhibitory activity for anti-obesity agents several plant, bacterial, fungal and marine species have been screened [8] [9] [10] . Currently, Orlistat is the only pharmacologic agent as pancreatic lipase inhibitor clinically approved in Europe. Orlistat is chemically also termed as tetrahydrolipstatin (l " Fig. 1 ). It is the saturated derivative of lipstatin, a natural PL inhibitor isolated from the bacterium Streptomyces toxytricini [11, 12] . But the use of Orlistat is compromised by unpleasant gastrointestinal adverse reactions like oily stools, oily spotting and flatulence [13] . The aim of present research is directed towards identifying novel inhibitors that lack some of these adverse reactions during patient treatment. The use of plant based resources as a potential platform for discovery and development of new drugs has become a lucrative research field in this context. One advantage of natural products is their presence in high concentrations in the gut after oral administration, because no further metabolic processes are necessary for an effect. Furthermore, systemic adverse effects are reduced by low absorption rates. Natural products generally have the advantage in being mild in their activity, in having a broad spectrum of possible multiple/synergetic effects and are considered to have less toxic and side effects than those construed on a totally synthetic based drug designing [14, 15] . Possible adverse Abstract ! Obesity and its associated diseases such as diabetes mellitus and coronary heart diseases are a major challenge for our society. An important target for the treatment of obesity includes the development of inhibitors of nutrient digestion and absorption. Inhibition of pancreatic lipase and the associated reduction of lipid absorption is an attractive approach for the discovery of potent agents. Currently, the only clinically approved pharmacologic agent as pancreatic lipase inhibitor is Orlistat. However, its usage is compromised by unpleasant gastrointestinal adverse reactions (oily stools, oily spotting, flatulence). The use of botanical materials as a potential source of new drugs is of increasing importance and application. Natural products that are interesting for obesity treatment are generally considered to have less toxic and side effects than totally synthetic drugs. One of the most important sources of potential pancreatic lipase inhibitors represents the class of polyphenols. This article summarizes most studied subclasses of polyphenols including flavonoids, hydroxycinnamic acids, hydroxybenzoic acids and lignans with pancreatic lipase inhibitory effects. A structural comparison of potent inhibitors shows an increased inhibitory effect depending on number and position of phenolic hydroxyl groups, degree of polymerization and elimination of glycosylation during digestion.
reactions of the natural products are rather unclear because metabolites resulting from microbial degradation in the human body are largely unknown. Some available data on the metabolic products of the ellagitannins (Urolitine) show a positive effect in the treatment of breast cancer by inhibition of proliferation of the affected cells [16] . Known negative side effects of polyphenols are the toxic effect of tannins to microorganisms and high concentrations of green tea polyphenols have been reported to cause liver and kidney damage in animal studies [17, 18] . However, these side effects were observed at high concentrations and for a clear understanding of potential adverse effects of dietary polyphenols further studies are necessary.
Obesity

!
Obesity is a medical condition caused by an imbalance between energy intake and expenditure. It is defined as abnormal or excess body fat accumulation to the extent that it may have an adverse effect on health [19] . Healthy body fat percentages vary depending on age, gender and body type. The normal amount of body fat is between 25-30 % for women and 18-23 % for men. Women are considered obese with a body fat percentage over 30 %, men with over 25 % [20] . A crude population measure of obesity is the body mass index (BMI). It is defined as the individ-ualʼs body mass in kg divided by the square of height in m [20] . According to WHO, an adult with a BMI equal to or more than 25 is considered overweight and is considered obese with a BMI of 30 or higher. Obesity can be divided into three categories: Grade I obesity: BMI 25-29.9, grade II obesity: BMI 30-39.9, and grade III obesity: BMI > 40 [15] . An elevated BMI value is a major risk factor for diseases such as cardiovascular diseases (mainly heart diseases and stroke), some cancers (endometrial, breast, and colon) and diabetes mellitus [21] . For a long time obesity was not recognized as an illness, but it certainly represents a typical example of diseases evolving from the advancement of civilization, being strongly related to lifestyle. In 2013, obesity was classified as a disease by the American Medical Association [22] .
Lipid Metabolism and Pancreatic Lipase
! Ingested fats are metabolized and absorbed in the intestine. They play important roles in energy supply, thermal regulation, and energy storage and as typical membrane components. Some lip-ids or associated fractions also function as transmission/reservoir agents for essential fatty acids and fat-soluble vitamins [23, 24] . About 95 % of the ingested fat can be absorbed by the human intestine. The main fat constituents (90 %) of a typical Western diet are triacylglycerides (TAGs). A TAG is an ester derived from a single molecule of glycerol and three fatty acids. Since TAGs cannot be absorbed, they must be hydrolyzed. The triacylglycerides are split via intestinal enzymes into monoacylglycerol and free fatty acids and can be absorbed by the duodenum [23] . Human pancreatic lipase [HPL, pancreatic triacylglycerol lipase (EC: 3.1.1.3)] is the main enzyme that breaks down dietary fats in the human digestive system. It is produced in the glandular cells of the pancreas and secreted into the duodenum [25, 26] . The HPL is a glycoprotein with a molecular weight of 52 kDa and consists of a 16 amino acid signal peptide and a mature protein of 449 amino acids [25] . The polypeptide chain is divided into two folding units, the N-terminal domain (amino acid residues 1-336) and the Cterminal domain (amino acid residues 337-449). While the Cterminal domain is responsible for the binding of the co-lipase, the N-terminal domain is catalytically active [25, 27] . The enzyme has a catalytic triad of the amino acids aspartic acid (176), histidine (263) and serine (152) in its active center that represents the lipolytic site. Serine (152) is essential for the hydrolytic activity of the enzyme. For the full functioning of the enzyme, the cofactor co-lipase is required [27] . The co-lipase is a non-enzymatic protein of 10 kDa and consists of 100 amino acids. It is secreted as a pro-form and is converted by tryptic cleavage of an N-terminal pentapeptide (enterostatin) in the much more active form [28] . The entering of the chyme in the duodenum induces the secretion of various hormones of the intestinal tract (cholecystokinin, secretin). These cause the secretion of bile salts and pancreatic enzymes in the intestine [29] . HPL hydrolyzes 40 % to 70% of TAGs [27] . Short-chain fatty acids (< C12) enter the portal vein and are transported directly into the liver. Free fatty acids and monoacylglyceroles, which were absorbed by the intestinal mucosa cells, are re-esterified to TAGs. These are incorporated into chylomicrons and reach the lymphatic vessels [30] . Enzyme levels and activity (especially lipases), physiochemical properties of dietary lipids and the presence of inhibitors or enhancers are the major determinants that can affect the lipolysis rates [23] .
Plant Products as Inhibitors of Pancreatic Lipase
! One screening strategy used in discovery of anti-obesity drugs is the search of potent lipase inhibitors from plant extracts. A variety of natural bioactive compounds present in plants have been screened for their potential effect on metabolic diseases including obesity. In particular, the class of secondary metabolites showed a high potential for inhibitors [27] . Inter alia, the inhibitory effect of tannins on proteases was detected in numerous studies [31] [32] [33] . They are able to form insoluble/soluble complexes with proteins due to nonspecific binding to the surface of the protein [31] . This makes them a good target for the treatment of obesity by PL inhibition. However, more research is needed for identification and characterization of effective lipase inhibitors. Crude plant extracts do not only contain active components but also non-active components. Possible multiple and synergetic effects of the active components complicate their identification and characterization. Also, the inhibitory mechanisms (reversible/irreversible) of plant products on PL remain unclear. It was generally attributed to the ability of secondary metabolites, e.g. tannins, to bind, complex and precipitate protein although some studies reported non-competitive inhibition mechanisms [34] . A second and much more innovative approach lies in using the structure of a known potent inhibitor, determining the binding site and pharmacore using in-silico computational modelling experiments and deriving the most likely potential natural structures (hits) using the available plant resources data banks and consequently testing these under experimental conditions to confirm/validate their activity. This review summarizes the most studied chemical classes of polyphenols with pancreatic lipase inhibitory activity including flavonoids, hydroxycinnamic acids, hydroxybenzoic acids and lignans. It is specialized in works where either pure polyphenols or crude plant extracts with a correlation to contained polyphenols have been tested for possible inhibition of PL. The most significant results up to October 2014 are presented.
Determination of pancreatic lipase activity
To determine the inhibitory potential of the natural compounds different in vitro enzyme assays are available. In most cases, fluorescence or absorption-based detection methods are used [35] [36] [37] [38] . The most commonly used fluorescent assay is based on the hydrolysis of an oleate ester of 4-methylumbelliferone (4-MUO) [36, [38] [39] [40] [41] . Under the presence of an active enzyme the highly fluorescent cleavage product 4-methylumbelliferone (4-MU) is released. The accompanying increase in fluorescence is proportional to lipase activity. The use of fluorescence-based assays has two decisive advantages: they are more sensitive than absorption-based assays and also turbid solutions are measurable. However, their use is often associated with higher costs. A commonly used in vitro absorption assay for the determination of PL activity is measuring the release of oleic acid from triolein [36] . Furthermore, various esters of p-nitrophenol (acetate, butyrate, octanoate) are used as substrates [35, 37, 42] . The released p-nitrophenol can be measured photometrically. Another typical lipase substrate for the photometric determination is 2,3-dimercapto-1-propanol tributyrate [43] . In addition to experimental work, a computer-based analysis is also possible. Jeong et al. used a surface response methodology for the assessment of the inhibitory potential [44] . In general, the synthetic product Orlistat was used as a positive control.
Polyphenols
In a variety of studies the beneficial effect of polyphenols on lipid metabolism could be demonstrated. They inhibit enzymes including PL, lipoprotein lipase (LPL), and glycerophosphate dehydrogenase (GPDH) [45] . Polyphenols containing extracts are able to lower body weight, fat weight, plasma free fatty acid levels, and hepatic lipid accumulation [46] . In the following, the current research results of the most studied subgroups of polyphenols for PL inhibitory activity are shown.
Flavonoids
Flavonoids represent the most common group of polyphenolic compounds in the human diet and are found ubiquitously in plants with kaempferol and quercetin as the main aglycon representatives [47, 48] . They protect the plant from harmful external influences, therefore the highest concentrations are found in the outer leaves or shells. Flavonoids consist of two aromatic carbon rings, benzopyran (A and C rings), and benzene (B ring) (l " Fig. 2 A) [47] . They can be divided into different subgroups: chalcones, dihydrochalcones, aurones, flavones, flavonols, dihy-droflavonoles, flavanones, flavanols, anthocyanidins, leucoanthocyanidins, proanthocyanidins, biflavonoids and isoflavonoids [49] . This classification is based on the degree of the oxidation of the C-ring, the hydroxylation pattern of the ring structure and the substitution of the C3-position [47] . Foods with a high flavonoid content are onions, legumes, broccoli, berries and orange juice [50] . Identified flavonoids with inhibitory potential are shown in l " Table 1. In the continued search for effective agents against obesity and metabolic syndrome, several plant species have been screened to find active compounds to inhibit PL. In the following proven structure-effect relationships and other features of the identified active components are explained in more detail: Isolated flavonoid compounds from Intsia palembanica Miq. (Leguminosae) were analyzed by Batubara et al. [43] . The tested substances were (−)-robidanol, (+)-epirobidanol, 4′-dehydroxyrobidanol, fustin, ampelopsin, naringenin, robinetin, myricetin, quercetin and 3,7,3′,5′-tetrahydroxyflavone. Lipase inhibitory activity assay was conducted using the 2,3-dimercapto-1-propanol tributyrate (BALB) method (in vitro enzyme assay). Seven of ten tested compounds showed a lipase inhibitory effect in a dose-dependent manner (IC 50 : 13.7-835.0 µM). (+)-epirobidanol, robinetin and naringenin showed an activation of lipase activity [43] . However, Assini et al. reported in further studies, that citrus flavonoids such as naringenin, hersperidin, nobiletin, and taugeretin showed a promising therapeutic effect for the treatment of metabolic dysregulation. In experimental and clinical studies lipidlowering, insulin-sensitizing, antihypertensive and anti-inflammatory effects could be confirmed [51] . C-glycoside flavones from methanolic extracts of the leaves of Eremochloa ophiuroides (Munro) Hack. (Poaceae) showed an inhibitory potential. IC 50 values were determined using p-nitrophenyl-butyrate as substrate (in vitro) and ranged from 18.5-50.5 µM. It was possible to estimate the optimal position and number of glycosyl groups on the flavone skeleton for pancreatic lipase inhibitory activity. The highest inhibitory effect showed Cglycosyl flavones with two sugar moieties at C6 [35] . Lychee (Litchi chinensis Sonn., Sapindaceae) flower-water extracts (LFWEs) were tested on lipase inhibition by measuring the rate of releasing of oleic acid from triolein (in vitro). The extracts contained phenolic acids, flavonoids, condensed tannins, anthocyanins, and proanthocyanidins. The following flavonoids could be identified in the extract: (+)-catechin, (−)-epicatechin, [53] . 4-MUO was used as a substrate to measure the pancreatic lipase inhibitory activity. It could be demonstrated that the replacement of rutinose (7-position, R 1 ) of hesperidin by neohesperidose (l " Fig. 3 ) caused a decrease of the inhibitory activity against porcine PL. Furthermore, hydroxy function in position 3′ (R 2 ), and methoxy function in po-sition 4′ (R 3 ) appear to favor inhibition. Eryngium bornmuelleri Náb. (Apiaceae) leaves were investigated for PL inhibition (substrate: 4-MUO, in vitro enzyme assay). Different extracts suppressed enzyme activity in a dose-dependent manner and showed a high phenolic content. Correlation analysis indicated that phenolic compounds were the main sources of the enzyme inhibitory activities. Rutin was detected as the major compound (70% of total phenolics) [38] . A variety of different polyphenols isolated from tea leaves [Camellia sinensis (L.) Kuntze, Theaceae] was evaluated for inhibitory potential against PL inhibition (substrate: 4-MUO, in vitro enzyme assay) by Nakai et al. [39] . Flavan-3-ol digallate esters, such as (−)-epigallo-catechin-3,5-digallate (IC 50 : 0.098 µM), showed a high activity of inhibition on lipase. Furthermore, it was observed that non-esterified flavan-3-ols [(+)-catechin, (−)-epicatechin] showed the lowest inhibitory effect (IC 50 : > 20 µM). The results suggest that the presence of galloyl moieties within the structure is responsible for enhancement of PL inhibition. Furthermore it could be demonstrated that the degree of polymerization of flavan-3-ols is important: the inhibitory effect of polymerized polyphenols (IC 50 : 0.28 µg/mL) from oolong tea was stronger than that of unfermented and unheated oolong tea (0.91 µg/mL). This hypothesis is supported by the results of Eidenberger et al. [54] . Polyphenols inhibit PL as long as the proportion of condensed polyphenols remains intact. Lipase inhibition is abolished when condensed polyphenols are hydrolysed by acidic treatment. Hotcompressed water (HCW) extracts of black tea (C. sinensis) residues were analyzed for PL inhibiting polyphenols by Yuda et al. [40] . The residues were treated with HCW from 100 to 200°C. All tested water extracts were able to inhibit PL but extracts obtained at 100 to 140°C showed the highest inhibition. Over 150°C lipase inhibition was decreased. PL inhibition was determined by measuring the rate of releasing of 4-MU from 4-MUO (in vitro).
The positive effect of tea (green, Oolong, black) and tea polyphenols has been confirmed already in human intervention studies [55] [56] [57] . Nagao et al. [58] examined the effect of Oolong tea extract with a defined concentration of catechins (690 mg/day) on the body weight of 35 men. After 12 weeks, a significant body weight (2.4 kg decrease), BMI (0.8 kg/m 2 decrease), waist circumference (3.4 cm decrease), and body fat mass (1.4 kg decrease) loss compared with baseline could be determined. Similar results were reported by Tsuchida et al. [59] . 43 male and 37 female participants were treated with a catechin-enriched green tea extract (588 mg catechins/day) for 12 weeks. Body weight (1.25 kg decrease), BMI (0.5 kg/m 2 decrease) and body fat mass (1.37 kg decrease) were reduced. Cocoa (Theobroma cacao L., Malvaceae) extracts, which are rich in proanthocyanins were analyzed by Gu et al. [60] . The results suggest that the degree of polymerization (DP) of proanthocyanins is an important factor in determining inhibitory activity. An inverse correlation between log IC50 and DP was observed. Also in vivo studies showed that proanthocyanidins reduced plasma trigylcerides by inhibiting the absorption of dietary lipids [ 1.38 mM) were tested as references on lipase inhibitory acitivity. The stronger inhibition of cyanidin compared to cyanidin-3,5-diglucoside suggests a higher inhibitory activity of anthocyanins after conversion to aglycone [64] .
Phenolic acids
Phenolic acids are, in addition to the flavonoids, one of the most commonly studied classes of secondary metabolites for lipase inhibition. The basic structure of phenolic acids is formed by hydroxycinnamic and hydroxybenzoic acids. Commonly, they occur as free acids, esters, glycosides or bound complexes. They are widely distributed in plant kingdom and have antioxidant, anticarcinogenic and antimicrobial activity [71] . In recent years it has been demonstrated that some of them have a potential to inhibit PL activity: Hydroxycinnamic acids are phenolic compounds with major importance for secondary metabolism in plants. They consist of a phenolic ring with a lateral three-carbon chain (C6-C3) (l " Fig. 2 B) . Hydroxycinnamic acids and their derivatives are ubiquitously present in fruits and in different parts of plants. Hydroxycinnamic acids are mainly present in form of esters and glycosides. Important examples are p-coumaric acid, ferulic acid, caffeic acid and sinapic acid [72] [73] [74] . Foods rich in hydroxycinnamic acids are certain types of vegetables (spinach, lettuce, potatoes), fruits (apples, blueberries), coffee and cereals [75] . Identified hydroxycinnamic acids with PL inhibitory potential are shown in l " In comparison, orange fruit showed the largest amount of hydroxycinnamic acids. However, it is not clear whether the detected cinnamic acids are responsible for the inhibitory effect of the fruits. For the determination of PL activity an in vitro enzymatic assay based on the hydrolysis of natural 1,2-diglyceride was used. Lemon (inhibition of 63.95 % at 0.1 mg/ mL) and lime (inhibition of 57.17 % at 0.1 mg/mL) fruits displayed the highest inhibitory effect on PL. However, no correlation of the detected hydroxycinnamic acids and the inhibitory potential could be determined [76] . Different hydroxycinnamic acids were analyzed by Karama et al. [42] . Ferulic and caffeic acid showed the highest PL inhibitory activity (IC 30 : 10 µM). Inhibition values were determined using pnitrophenyl-acetate as substrate (in vitro). By comparing the results, it is clear that compounds with a methoxy group are weak inhibitors of PL. Also the position of hydroxyl groups in the ring affects lipase inhibition. Inhibitory effects of hydroxyl groups in ortho-position were stronger than at para-position. Hydroxybenzoic acids are phenolic C6-C1 compounds. They consist of a benzene ring with an added carboxy and hydroxy group as substituent (l " Fig. 2 C) . They are mainly present in form of esters or glycosides, mostly of vanillic acid, salicylic acid and gentisic acid [55] . Hydroxybenzoic acids are found in common plants such as grapefruit, carrots, onions, grapes and red fruits [78, 79] . Identified hydroxybenzoic acids with PL inhibitory potential are shown in l " Table 3 . In direct comparison, derivatives of hydroxy- benzoic acids inhibited less powerfully the activity of PL than hydroxycinnamic acids. Comparing the results with the chemical structure of hydroxybenzoic acids, the influence of methoxy groups in the molecule (less potent) and hydroxyl groups (more potent) can be seen. Furthermore, it could be concluded that a carboxy group takes part in the activity between phenolic acids and the active center of the lipase. Also, the size of the molecule has an influence on a potential lipase inhibition [42] . 
Lignans
Lignans are dimers of phenylpropanoid units linked by the central carbons of their side chains (l " Fig. 2 D) . In plants, lignans and their higher oligomers act as defensive substances. After oral intake of lignan precursors, they are metabolized to their active form. Lignan precursors are found in a wide variety of plant foods, including flax seeds, sesame seeds, legumes, whole grains (rye, oats, barley), fruits (berries), and vegetables [79, 81, 82] . Identified lignans and their derivatives with PL inhibitory potential are listed in l " Table 4 . Isolated compounds from Fraxinus rhynchophylla Hance (Oleaceae) were tested on their inhibitory effects on pancreatic lipase activity by hydrolysis of 4-nitrophenyl butyrate (in vitro). Five isolated compounds (four sesquilignans and one lignan, l " Table 4 ) showed a significant inhibition. Other lignans and coumarinolignans had only weak effects [83] .
Conclusion
!
Orlistat is the only pharmacologic agent clinically approved as pancreatic lipase inhibitor in Europe. However, the application of the synthetic drug is associated with a variety of undesirable side effects. Searching for potential inhibitors of PL from natural origin is a current research topic. Previously, a variety of polyphenols were detected as potential active compounds. A structural comparison of known inhibitors makes the following conclusions:
The inhibitory effect of active flavonoids depends on the number and position of phenolic hydroxyl groups. A high number increases the inhibitory effect. Furthermore, non-esterified flavan-3-ols as (+)-catechin and (−)-epicatechin showed a lower inhibition than flavan-3-ol esters. The presence of galloyl moieties within the structure and the polymerization of flavan-3-ols are required for enhancement of PL inhibition. Analysis of flavonoids and anthocyanins suggests a higher inhibitory activity after elimination of glycosylation. Also, the degree of polymerization of proanthocyanins is important. At the investigation of phenolic acids it could be demonstrated that hydroxybenzoic acids inhibit less powerfully the activity of PL than hydroxycinnamic acids. An influence of methoxy groups in the molecule (less potent) and hydroxyl groups (more potent) could be detected. In addition, the size of the molecule and the position of hydroxyl groups in the ring affect lipase inhibition. These results serve as a first basis for finding new natural structures with PL inhibitory activity. By using computational modelling experiments, new potential therapeutic antiobesity agents with less side effects compared to the clinically approved pharmacologic agent Orlistat can be detected. However, further identification and characterization of natural compounds with anti-lipase action is necessary.
